Pegylated Liposomal Doxorubicin as Adjuvant Therapy for Stage I-III Operable Breast Cancer

Lu Y.-C.Ou-Yang F.U.Hsieh C.-M.KING-JEN CHANGChen D.-R.Tu C.-W.Wang H.-C.Hou M.-F.2022-08-122022-08-1220161791-7549https://www.scopus.com/inward/record.uri?eid=2-s2.0-85010010600&partnerID=40&md5=8da75e6412f3de4c943052d79a05c50ahttps://scholars.lib.ntu.edu.tw/handle/123456789/616617Pegylated Liposomal Doxorubicin as Adjuvant Therapy for Stage I-III Operable Breast Cancerjournal article269128292-s2.0-85010010600